Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    30-March-2001      
Issue 89 Next Update - 14:00 UTC 08:00 EST    31-March-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Injectable Anesthesia Drug Being Withdrawn From Market

Raplon (rapacuronium bromide)

The injectable anesthesia drug Raplon (rapacuronium bromide) is being voluntarily withdrawn from the market after its manufacturer received reports indicating that the drug may be associated with bronchospasm - a mild to severe inability to breathe normally that can lead to permanent injury or death. Five deaths, reported to the manufacturer, occurred during the administration of Raplon.

The drugís sponsor, Organon Inc., of West Orange, N.J., contacted FDA and sent a letter beginning March 27, 2001, to all anesthesiologists, hospital pharmacists, and other consignees of the drug, notifying them of the voluntary withdrawal of the drug and providing information on how to return unused inventory back to the company.

Raplon was administered in hospital and other surgical settings as a muscle relaxant for breathing tube placement and surgery. Other drugs on the market may be prescribed for the same purpose, and this withdrawal does not affect the overall availability of anesthesiology drugs.

FDA approved Raplon for this indication in August 1999 after more than a yearlong review of Organonís new drug application. Although the drugís approved labeling did note the occurrence of bronchospasm in a small percentage of clinical trial patients receiving the drug, post- marketing reports indicate that the risk of injury from bronchospasm may be greater than was suggested in clinical trials.

Patients and healthcare providers with questions about this product withdrawal can contact the company at Customer Service 1-800-241-8812.

 


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 
Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.